Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Caisson Biotech, a provider of half-life extension and drug delivery platforms, has established a global manufacturing partnership with CordenPharma International, a full-service Contract Development & Manufacturing Organization (CDMO) manufacturing ...
read more
Pharmaceutical Product Development, LLC has announced that Hacene Mekerri has joined the global contract research organization (CRO) to serve as vice president of its central laboratory organization.
read more
Charles River Laboratories International has entered into a strategic partnership with BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development.
read more
Wednesday, April 13, 2016
Laboratory Corporation of America Holdings® (LabCorp®) has announced that Covance Drug Development has completed an expansion of its now approximately 4,500 square meter (48,000 square foot) central laboratory in Geneva, Switzerland, the largest of ...
read more
Imprimis Pharmaceuticals, a pharmaceutical company focused on the development and commercialization of proprietary and customizable drug formulations, announced that it has filed for registration of its ImprimisRx TX pharmacy, located in Allen, Texas...
read more
We’re proud of our ISO 17025 accreditation as it reflects the broad scope of our capabilities. Also, it’s gratifying to know that we’re one of the very few labs, nationally, to hold accreditation for Elemental Impurities.” Quantex Laboratories’ ...
read more
Cryoport, Inc. has announced the launch of a new Temperature Controlled Logistics Consulting Division to assist life sciences companies in developing strategies for global cold chain logistics management and contingency options to protect their ...
read more
WuXi AppTec an open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, has announced that WuXi Lab Testing Division (LTD)'s late-and commercial-stage analytical and ...
read more
Medidata a provider of cloud-based solutions for clinical research in life sciences, has announced results of a research study on the impact of protocol changes made while a clinical trial is underway, conducted with the Tufts Center for the Study of...
read more
The contract development and manufacturing organization, Recipharm AB has completed the acquisition of a majority stake in Nitin Lifesciences Limited, an Indian sterile injectables CMO, currently owned by the Sobti family.
read more
Diversis Capital, LLC, a Los Angeles-based private equity firm focused on acquiring and growing small- and middle-market companies, today announced that it has acquired the majority of the assets of Caligor Rx, Inc.
read more
Laboratory Corporation of America has announced that Jonathan Zung, Ph.D., has been named group president, Clinical Development & Commercialization Services for Covance Drug Development.
read more
Juno Therapeutics, a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, and WuXi AppTec, an open-access R&D capability and technology platform company serving the pharmaceutical, ...
read more
WellSpring Pharma Services, a specialist in formulation, development and manufacturing for a wide range of solid, semi-solid and non-sterile liquid products, has announced a $3 million capital investment in new equipment as well as a new strategic ...
read more
CPC Scientific has announced that the CPC Good Manufacturing Practice (GMP) facility in Hangzhou, China has successfully passed its fourth U.S. Food and Drug Administration (FDA) inspection. No Form 483 observations were issued.
read more